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Summary 
The 43 kDa AChR-associated protein rapsyn is re- 
quired for the clustering of nicotinic acetylcholine re- 
ceptors (AChRs) at the developing neuromuscular 
junction, but the functions of other postsynaptic pro- 
teins colocalized with the AChR are less clear. Here 
we use a fibroblast expression system to investigate 
the role of the dystrophin-glycoprotein complex (DGC) 
in AChR clustering. The agrin-binding component of 
the DGC, dystroglycan, is found evenly distributed 
across the cell surface when expressed in fibroblasts. 
However,  dystroglycan colocalizes with AChR-rapsyn 
clusters when these proteins are coexpressed. Fur- 
thermore, dystroglycan colocalizes with rapsyn clus- 
ters even in the absence of AChR, indicating that 
rapsyn can cluster dystroglycan and AChR indepen- 
dently. lmmunofluorescence staining using a poly- 
clonal antibody to utrophin reveals a lack of staining of 
clusters, suggesting that the immunoreactive species, 
like the AChR, does not mediate the observed rapsyn- 
dystroglycan interaction. Rapsyn may therefore be a 
molecular link connecting the AChR to the DGC. At 
the neuromuscular synapse, rapsyn-mediated linkage 
of the AChR to the cytoskeleton-anchored DGC may 
underlie AChR cluster stabilization. 
Introduction 
Efficient signal transmission between neurons and their 
targets depends on the formation of highly specialized 
structures both pre- and postsynaptically. At the neuro- 
muscular junction, a particularly striking example of mo- 
lecular specialization is the clustered distribution of nico- 
tinic acetylcholine receptors (AChRs). Prior to innervation, 
AChRs are evenly distributed along the muscle mem- 
brane. Following contact with the motor nerve ending, the 
concentration of AChRs increases dramatically and even- 
tually reaches 10,000 molecules/urn2 in the postsynaptic 
membrane, while only a few micrometers away the density 
of AChRs is 1 OOO-fold lower (Fertuck and Salpeter, 1974; 
Bevan and Steinbach, 1977). Agrin, a nerve-derived extra- 
cellular matrix protein, provides at least part of the signal 
that induces the process of AChR clustering (reviewed in 
McMahan et al., 1992; Nastuk and Fallon, 1993). 
A number of proteins associated with the postsynaptic 
membrane at the neuromuscular junction have been impli- 
cated in the molecular mechanisms underlying formation 
and maintenance of AChR clusters (reviewed in Apel and 
Merlie, 1995). Experiments employing extraction of extrin- 
sic membrane proteins from AChR-rich membranes dem- 
onstrated that removal of 43, 58, and 87 kDa molecular 
weight species correlated with increases in the mobility 
of the receptor (Barrantes et al., 1980; Lo et al., 1980; 
Cartaud et al., 1981; Rousselet et al., 1982) without affect- 
ing its ligand binding or gating properties (Neubig et al., 
1979; Elliot et al., 1980). The 43 kDa AChR-associated 
protein, rapsyn (Frail et al., 1988), is precisely colocalized 
with AChR (Froehner et al., 1981; Sealock et al., 1984), 
and accumulating evidence indicates a direct role for 
rapsyn in AChR clustering (reviewed in Phillips and Merlie, 
1992). Rapsyn is identical to the AChR-associated protein 
referred to as the 43 kDa protein, but we encourage the 
use of the name rapsyn to distinguish this protein from 
other 43 kDa components of the postsynaptic membrane. 
The 58 kDa (recently renamed syntrophin; Adams et al., 
1993) and 87 kDa proteins also colocalize with AChR at the 
neuromuscular junction, but are present extrasynaptically 
as well (Froehner et al., 1987; Carr et al., 1989). The pre- 
cise roles of syntrophin and the 87 kDa protein in AChR 
clustering remain unclear, but biochemical evidence indi- 
cates that both proteins associate in a complex with the 
cytoskeletal protein dystrophin extrajunctionally, and with 
the dystrophin-related protein utrophin at the synapse 
(Butler et al., 1992; Matsumura et al., 1992; Wagner et 
al., 1993; Kramarcy et al., 1994; Suzuki et al., 1994; Ahn 
and Kunkel, 1995; Suzuki et al., 1995; Yang et al., 1995). 
Independent lines of research investigating the role of 
dystrophin and utrophin in muscle membrane integrity 
have identified several additional protein components in 
a complex containing syntrophin and the 87 kDa protein 
(see Figure 6). This dystrophin-glycoprotein complex 
(DGC) was first isolated based on its tight association with 
dystrophin (Ervasti et al., 1990; Yoshida and Ozawa, 
1990), but utrophin has subsequently been shown to also 
associate with the DGC (Matsumura et al., 1992). The 
DGC is composed of t ransmembrane proteins of 25, 35, 
43 (8dystroglycan and yet another distinct 43 kDa protein 
that is less well characterized), and 50 kDa (adhalin); a 
heavily glycosylated extracellular protein (a-dystrogly- 
can); and syntrophin, an intracellular 59 kDa protein triplet 
previously characterized as an AChR-associated protein 
(Ervasti et al., 1990; Yoshida and Ozawa, 1990; Ervasti 
and Campbell, 1991; Yoshida et al., 1994). An 87 kDa 
species frequently found in DGC preparations is likely to 
be the homolog of the Torpedo 87 kDa AChR-associated 
protein (Ervasti et al., 1990; Yoshida and Ozawa, 1990). 
Like syntrophin and the 87 kDa protein, other components 
of the DGC, namely dystroglycan and adhalin, are found 
colocalized in AChR clusters in cultured muscle cells 
(Campanelli et al., 1994; Gee et al., 1994). Utrophin is also 
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closely colocalized with clustered AChRs at the adult and  
developing neuromuscular  junction (Khurana et al., 1991;  
Ohlendieck et al., 199la; Bewick et al., 1992;  Phillips et 
al., 1993)  and  in C2 myotubes utrophin is concentrated 
mainly at large AChR clusters rather than small ones,  im- 
plying that utrophin may be  involved in the enlargement 
of AChR clusters rather than in the initial s tages of their 
formation (Phillips et al., 1993).  Many  other observat ions 
have likewise suggested that AChR clusters are stabilized 
and  maintained by  interacting with the underlying cy 
toskeleton (Pumplin and  Bloch, 1993).  Together,  these 
data indicate an  important role for the DGC in AChR clus- 
tering. The  recent identification of a-dystroglycan as  an  
agrin-binding protein has  further focused attention on  the 
role of the DGC in AChR clustering (Bowe et al., 1994;  
Campanell i  et al., 1994;  Gee  et al., 1994;  Sugiyama et 
al., 1994).  Strong biochemical ev idence demonstrates that 
agrin binds to a-dystroglycan, but because experiments 
to address the functional signif icance of this binding have 
produced conflicting results, it remains to be  conclusively 
determined whether binding of agrin to dystroglycan is a  
necessary requirement for AChR clustering. Regardless, 
the DGC may play a  structural role in AChR clustering, 
perhaps by  providing the cytoskeletal anchor  necessary 
for cluster stabilization and  maintenance. Efforts to under-  
s tand the molecular organization of the DGC, AChR, and  
associated proteins can therefore advance our  under-  
standing of the mechanisms underlying AChR clustering, 
even if dystroglycan is not the receptor that initiates agrin 
signal transduction. 
In this paper,  we explore the role of the DGC in AChR 
clustering by  examining the molecular interactions be-  
tween components  of the DGC and  AChR complex. While 
research has  led to a  model  for the molecular organization 
of the DGC and  its associated proteins, it remains com- 
pletely unclear how this network of proteins is l inked to 
the AChR. Here we have expressed recombinant proteins 
in a  fibroblast cell line to investigate the molecular nature 
of the link between the AChR and  the DGC complex. This 
fibroblast system allows us  to reconstitute systematically 
interactions that normally occur  at the neuromuscular  syn- 
apse  in order to study the molecular organization of the 
postsynaptic apparatus (Phillips et al., 1991  a, 1991  b; Mai- 
mone  and  Merlie, 1993).  Previous studies demonstrated 
that AChRs expressed in these cells, which do  not contain 
endogenous  rapsyn or AChR, were distributed evenly on  
the cell surface. However,  when coexpressed with rapsyn, 
AChRs became redistributed into large cell surface clus- 
ters that colocalized with rapsyn (Phillips et al., 199la). 
In this study, we examine the localization of dystroglycan 
when expressed in fibroblasts by  itself and  in combinat ion 
with rapsyn and  AChR. Our  results suggest  that rapsyn 
can cluster dystroglycan and  that the AChR is not needed  
for the interaction between rapsyn and  dystroglycan. Fur- 
thermore, a  protein recognized by  a  polyclonal ant ibody 
to utrophin does  not appear  to mediate the rapsyn-dys- 
troglycan interaction. Rapsyn may therefore be  the molec- 
ular link connect ing the AChR to the DGC. 
Results 
Expression of Dystroglycan in QT-6 cells 
Before investigating the role of recombinant dystroglycan 
in our  fibroblast expression system, we wanted to deter- 
mine whether the quail fibroblast cells (QT-6) contain en-  
dogenous  dystroglycan. Dystroglycan is expressed in a  
variety of t issues ( Ibraghimov et al., 1992)  al though other 
members  of the DGC complex appear  to be  largely muscle 
specific (Hoffman et al., 1987;  Lev  et al., 1987;  Roberds 
et al., 1993;  Wagner  et al., 1993;  Yamamoto et al., 1994).  
W e  used antibodies directed against the heavily glycosyl- 
ated 156  kDa extracellular agrin-binding component ,  
a-dystroglycan, and  the 43  kDa t ransmembrane protein, 
f3-dystroglycan. A polyclonal ant ibody designated FP-B, 
which recognizes both a- and  6-dystroglycan in rabbit 
skeletal muscle, cross-reacts with the quail muscle 
f3-dystroglycan but not quail a-dystroglycan (data not 
shown).  Western blot analysis of extracts from non-  
transfected QT-6 cells using FP-B revealed that QT-6 cells 
contain no  endogenous  8-dystroglycan (Figure 1A). An 
anti-a-dystroglycan ant ibody that recognizes a  156  kDa 
band  in rabbit and  quail skeletal muscle likewise failed to 
detect an  immunoreact ive species in QT-6 cells (Figure 
IA). As this ant ibody appears  to require carbohydrate 
modifications for recognit ion of a-dystroglycan (Ervasti 
and  Campbell ,  1993)  it is possible that an  incompletely 
glycosylated form of a-dystroglycan is found endoge-  
nously in QT-6 cells. This possibility is extremely unlikely, 
however,  since a- and  f3-dystroglycan are der ived from a  
single polypeptide precursor and  QT-6 cells contain no  
endogenous  f3-dystroglycan. 
The  absence of immunoreact ive dystroglycan in QT-6 
cells made  it possible to follow the expression of recombi- 
nant  rabbit dystroglycan introduced by  transfection. West-  
ern blot analysis revealed robust expression of dystrogly- 
can in cells transfected with a  dystroglycan expression 
construct (Figure 1A). Two bands  were detected by  the 
FP-B antibody, which recognizes both a- and  pdystrogly- 
can. The  43  kDa band  corresponds to the molecular weight 
of 8-dystroglycan. This 43  kDa band  recognized by  the 
dystroglycan ant ibody is not rapsyn, which also migrates 
as  a  43  kDa protein, since the FP-B ant ibody showed no  
cross-reactivity when rapsyn was expressed alone in QT-6 
cells (Figure 1A). A 6-dystroglycan-specif ic ant ibody rec- 
ognized the 43  kDa band  only, and  not the higher molecu- 
lar weight band.  This confirmed the identity of the 43  kDa 
band  as  f3-dystroglycan and  further indicated that the 
higher molecular weight band  is not the uncleaved dystro- 
glycan precursor,  which would contain the 6-dystroglycan 
epitope, but rather represents a-dystroglycan (Figure 1A). 
The  diffuse a-dystroglycan band  around 80  kDa is smaller 
than native rabbit muscle a-dystroglycan, which migrates 
at approximately 156  kDa, as  shown in Figure 1A. The  
difference between the QT6-expressed recombinant form 
and  the muscle form is most likely due  to incomplete glyco- 
sylation in QT-6 cells of the 57  kDa a-dystroglycan protein 
core(lbraghimovetal.,  1992;  Ervastiandcampbell ,  1993).  
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Indeed, a-dystroglycan-specific antibodies that have car- 
bohydrate moieties as part of their epitope did not recog- 
nize the 80 kDa band (data not shown). 
Recombinant dystroglycan expressed in QT-6 cells was 
found evenly distributed across the cell as assessed by 
immunofluorescence microscopy (Figure 16). Both per- 
meabilized and nonpermeabilized (data not shown) trans- 
fected cells showed specific staining with an antibody that 
recognizes both a- and f3-dystroglycan. The dystroglycan 
expressed must therefore be exposed on the cell surface, 
available for staining. Thus, our results indicate that re- 
combinant dystroglycan expressed in QT-6 cells is cor- 
rectly processed to yield extracellular a-dystroglycan and 
membrane-spanning fSdystroglycan. The even distribu- 
tion of dystroglycan across the cell surface demonstrates 
that, unlike rapsyn, dystroglycan expressed alone in QT-6 
cells does not form clusters. 
Figure 1. Expression of Dystroglycan in QT-6 
Cells 
(A) Western blot analysis of rabbit mucle, quail 
muscle, and quail QT-6 cells (transfected and 
nontransfected) reveals the absence of endog 
enous c- and 6-dystroglycan in QT-Gfibroblasts 
and confirms the expression of recombinant 
U- and 6.dystroglycan in QT.6 cells transfected 
with a dystroglycan expression construct. For 
anti-a-dystroglycan staining, 100 pg of rabbit 
muscle crude surface membranes, 250 ug of 
quail muscle crude surface membranes, or 500 
ug of SDS-solubilized whole-cell pellets of 
QT.6 ceil cultures was loaded per lane. For the 
rest of the blots, different volumes of samples 
of SDS-solubilized whole-cell pellets from 
transfected QT-6 cells were loaded to correct 
for variable transfection efficiency; generally 1 
ug of total protein from transfected and non- 
transfected cells was loaded per lane. Nitro- 
cellulose blots were stained with the antibody 
indicated above each blot: an antibody to a-dys- 
troglycan, a polyclonal antibody(FP-B) that rec- 
ognizes both a- and 6-dystroglycan, an antr- 
body to !3-dystroglycan, and an anti-rapsyn 
antibody. Molecular weight markers (in kilodal- 
tons) are indicated at left 
(B) Recombinant rabbit dystroglycan ex- 
pressed in QT.6 fibroblasts is evenly distrrb- 
uted across the cell surface. QT.6 cells were 
transfected with an expression construct for 
dystroglycan (left) or mock-transfected with an 
equal amount of pSK DNA (right). Permeabrl- 
rzed cells were stained with a polyclonal antr- 
body (FP-B) that recognizes rabbit a- and 
h-dystroglycan. Nontransfected cells stained 
for dystroglycan exhibited no staining above 
background, confirming the specificrty of dys- 
troglycan staining and the lack of an endoge- 
nous immunoreactive dystroglycan. Cells that 
were not permeabilized before fixation also 
showed a diffuse pattern of staining (data not 
shown), confirming that the recombinant dys- 
troglycan is correctly processed in QT.6 cells 
to yield ceil surface a-dystroglycan accessible 
to extracellular staining. Bar, 10 urn. 
Dystroglycan Colocalites with 
AChR-Rapsyn Clusters 
Dystroglycan is concentrated at the sites of agrin-induced 
AChR clusters in C2 cells and is found both at the neuro- 
muscular junction and throughout the sarcolemmal mem- 
brane in skeletal muscle (Ervasti and Campbell, 1991; 
Campanelli et al., 1994; Gee et al., 1994). To determine 
whether dystroglycan associates with clusters formed in 
QT-6 fibroblasts, which should not express many muscle- 
specific proteins, we coexpressed rapsyn, AChR, and dys- 
troglycan in QT-6 cells and determined the distribution 
of each protein using immunofluorescence microscopy. 
Dystroglycan was found colocalized with AChR and rapsyn 
in AChFl-rapsyn clusters (Figure 2A). The codistribution 
was remarkably precise; dystroglycan staining exactly du- 
plicated the rapsyn or AChR staining of clusters. The size 
and shape of clusters varied considerably, yet all clusters 
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Figure 2. Dystroglycan Colocalizes with AChFU 
43K Clusters in Transfected QT-6 Cells 
(A) QT-6 cells transfected with rapsyn, AChR, 
and dystroglycan expression constructs were 
permeabilized and double stained pairwise 
with anti-rapsyn, anti-AChR, and antidystrogly- 
can antibodies as indicated beneath each 
panel, followed by appropriate affinity-purified, 
species-specific secondary antibodies. Dystro 
glycan staining was found precisely colocalized 
with AChR and rapsyn staining of AChR- 
rapsyn clusters. Appropriate controls for fluo- 
rescent cross-bleed and antibody specificity 
were carried out in these and all subsequent 
immunofluorescence experiments (see Experi- 
mental Procedures). Bar, 10 pm. 
(6) QT-6 cells transfected with AChR and dys- 
troglycan were stained as in (A) to visualize 
AChR and dystroglycan staining. In the ab- 
sence of rapsyn, both AChR and dystroglycan 
staining was evenly distributed across the cell. 
Bar, 10 pm. 
AChR dystroglycan 
rapsyn 
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had sharply defined boundaries and were usually present 
on all surfaces of the cell. Dystroglycan-containing clus- 
ters were indistinguishable from clusters formed with 
rapsyn and AChR (Maimone and Merlie, 1993). 
AChR-rapsyn clusters form in QT-6 cells without the 
addition of agrin (data not shown) (Phillips et al., 1991 a). 
Surprisingly, dystroglycan association with AChR-rapsyn 
clusters in QT-6 cells also occurred in the absence of agrin. 
Furthermore, the addition of agrin did not cause any de- 
tectable changes in dystroglycan-containing cluster fre- 
quency or morphology. We were unable to determine 
whether the recombinant dystroglycan expressed in QT-6 
cells successfully bound agrin in these experiments. 
Nonetheless, the absence of an agrin requirement for clus- 
ter formation in QT-6 cells suggests that at least some of 
the molecular events leading to cluster formation occur 
independently of agrin stimulation, or that pathways regu- 
lating clustering may be constitutively activated in QT-6 
cells. 
Dystroglycan colocalization with AChR-rapsyn clusters 
was a very frequent phenotype; 81% of the cells with 
AChR-rapsyn clusters also exhibited dystroglycan stain- 
ing at clusters (Figure 3). The remaining 19% of the cells, 
which exhibited no detectable dystroglycan staining at 
AChR-rapsyn clusters, generally had only very weakly flu- 
orescent clusters when viewed for AChR staining; it is 
likely that the dystroglycan staining of these clusters was 
merely beneath the limits of detection. When dystroglycan 
and AChR were expressed in the absence of rapsyn, both 
proteins were found to be evenly distributed, suggesting 
that rapsyn is clearly necessary for the formation of clus- 
ters containing AChR and dystroglycan (see Figure 28). 
Dystroglycan Interacts with Rapsyn Clusters 
Independently of AChR and Utrophin 
or Dystrophin 
We next wanted to determine whether AChR is necessary 
Figure 3. Frequency of Staining Patterns 
QT-6 cells were transfected with expression 
constructs for rapsyn. dystroglycan, and AChR, 
In various combinations or each alone, as mdi- 
cated on the X axis. Stained cells were viewed 
by immunofluorescence microscopy. Cov- 
erslips were scanned systematically, and suc- 
cessfully transfected cells, as judged by stain- 
ing above background for each introduced 
protein, were examined for the presence of 
clusters. Bars represent the percentage of 
transfected cells exhibiting clusters containing 
the particular protein being tested. Dystro- 
glycan colocalization with AChR-rapsyn and 
rapsyn clusters is a very frequent phenotype. 
Some cells with AChR-rapsyn or rapsyn clus- 
ters did not show corresponding dystroglycan 
staining of clusters, but all dystroglycan-stained 
clusters also stained with anti-rapsyn or anti- 
AChR antibodies. Representative data are pre- 
sented from one of two independent transfec- 
tion experiments for each experimental 
condition. At least 200 transfection-positive 
cells were scored for each condition per exper- 
iment. 
for dystroglycan association with AChR-rapsyn clusters. 
As demonstrated previously, rapsyn was organized into 
clusters in cells transfected with rapsyn alone, suggesting 
that rapsyn aggregation may be the primary event in AChR 
cluster formation (Figure 4A). When cells were transfected 
with rapsyn and dystroglycan without AChR, dystroglycan 
was found colocalized with rapsyn clusters (Figure 4B). 
This colocalization was not due to cross-reactivity of the 
dystroglycan primary or secondary antibody, as indicated 
by the lack of specific staining for dystroglycan in cells 
transfected with rapsyn only (Figure 4A). Numerous other 
membrane proteins, including N-cadherin, concanavilin- 
A- and wheat germ agglutinin-binding glycoproteins, glu- 
cose transporters, CD8, and a potassium channel, have 
previously been shown not to be clustered by rapsyn, indi- 
cating the specificity of AChR and dystroglycan clustering 
by rapsyn (Froehner et al , 1990; Maimone and Merlie, 
1993; Yu and Hall, 1994; M. M. Maimone, W. D. Phillips, 
and J. P. M., unpublished data). Furthermore, the colocali- 
zation of dystroglycan with rapsyn clusters was a fre- 
quently observed phenomenon, as 74% of the cells with 
rapsyn clusters also showed positive staining for dystro- 
glycan in clusters (see Figure 3). These results indicate 
that dystroglycan can associate with rapsyn clusters in 
the absence of AChR and further support a central role 
for rapsyn in assembly of the postsynaptic apparatus. 
The observed association of rapsyn with dystroglycan 
could be a direct interaction between the two proteins, or 
the interaction could be mediated by one or more addi- 
tional proteins. Our  results show that AChR is not neces- 
sary for the rapsyn-dystroglycan association, but one or 
more endogenous proteins in the QT-6 fibroblasts could 
play a role in the interaction. For example, QT-6 cells may 
express AChR-associated or DGC proteins that could po- 
tentially mediate rapsyn binding to dystroglycan. We were 
unable to determine whether most of these putative media- 




Figure 4. Dystroglycan Associates with Rapsyn 
Clusters in the Absence of AChR 
(A) QT-6 cells transfected with rapsyn only 
(B) Permeabilized cells transfected with rapsyn 
RAPSYN + DYSTROGLYCAN 
and dystroglycan were stained as in (A). Dys- 
troglycan staining was found colocalized with 
rapsyn clusters, indicating that dystroglycan 
can associate with raosvn clusters in the ab- 
rapsyn dystroglycan 
rapsyn dystroglycan 
of species cross-reactivity of available antibodies with the 
quail proteins (data not shown). Using Western blot analy- 
sis, we tested available antibodies for their ability to recog- 
nize immunoreactive species in rabbit muscle, quail mus- 
cle, and QT-6 fibroblasts. While antibodies to the 87 kDa 
protein, thesyntrophin triplet, the 35 kDa DGC component, 
and dystrophin positively identified bands of the correct 
molecular weight in rabbit muscle extracts, these anti- 
bodies failed to cross-react with any species in quail mus- 
cle or QT-6 cells. We cannot, therefore, definitively rule 
out the participation of endogenous forms of these mole- 
cules in rapsyn-mediated clustering of dystroglycan. How- 
ever, antibodies against adhalin recognized a 50 kDa spe- 
cies in quail muscle but not in QT-6 cells (data not shown), 
making it possible to rule out this DGC protein as a media- 
tor of the rapsyn-dystroglycan interaction. In addition, an 
antibody designated BHll, raised against a C-terminal 
fragment of utrophin (Khurana et al., 1991), recognized 
a single species in QT-6 cells (Figure 5A). Western blot 
analysis further revealed that this antibody recognized two 
bands in rabbit and quail muscle. Owing to the high degree 
of homology between dystrophin and utrophin, it is possi- 
ble that BHll cross-reacts with both proteins. At present, 
it is difficult to determine which of the discrete bands in 
quail muscle corresponds to utrophin or dystrophin; it is 
therefore unclear which of the two proteins represents the 
immunoreactive species in QT-6 cells. In the remainder 
of the paper, we will refer to the protein recognized by 
BHl 1 as utrophinldystrophin. However,  as full-length dys- 
trophin is expressed primarily in muscle, with lower levels 
in brain, it is likely that the immunoreactive species in QT-6 
fibroblasts represents utrophin (Hoffman et al., 1987; Lev 
et al., 1987; Chamberlain et al., 1988; Nude1 et al., 1988). 
To determine whether the endogenous utrophinldys- 
trophin in QT-6 cells mediates the rapsyn-dystroglycan 
interaction, transfected cells were stained with the BHll 
antibody. This antibody stains the neuromuscular junction 
in mouse and quail muscle sections (Khurana et al., 1991; 
P. G. Noakes, W.-X. A. Guo, and J. P. M., unpublished 
data) and would therefore be expected to recognize en- 
dogenous utrophinldystrophin during immunostaining of 
the quail fibroblasts. lmmunofluorescence staining pat- 
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terns in QT-6 cells indicated an even distribution of 
utrophin/dystrophin throughout the cell, with no observed 
concentration of the immunoreactive species at dystrogly- 
can-containing clusters (Figure 56). Utrophinldystrophin 
does not ther efore appear to mediate the rapsyn-dystro- 
glycan interac :tion. Together, these data indicate that rap- 
syn interacts independently with dystroglycan and the 
AChR, and tt lerefore could serve as a molecular link be- 
Figure 5. UtrophinlDystrophin Does Not Medi- 
ate the Rapsyn-Dystroglycan Interaction 
(A) A total of 100 pg of rabbit muscle crude 
surface membranes (lane l), 250 pg of quail 
muscle crude surface membranes (lane Z), or 
500 vg of SDS-solubilized whole-cell pellets of 
QT-6 cell cultures (lane 3) was loaded per lane 
on a 3%-12% gradient gel, and blots were 
stained with a rabbit polyclonal antibody 
(BH11) raised against a C-terminal fragment of 
utrophin. Molecular weight markers (in kilodal- 
tons) are indicated at left 
(6) Permeabilized QT-6 cells transfected with 
rapsyn, AChR, and dystroglycan were double 
labeled with an anti-AChR antibody and a poly- 
clonal antibody raised against the C-terminal 
fragment of utrophin, as indicated beneath 
each panel. As depicted in the top two panels, 
utrophinldystrophin staining was not detected 
at AChR-rapsyn clusters. To ensure that the 
observed diffuse staining pattern represented 
specific staining above background, parallel 
coverslips were stained in the absence of either 
the anti-AChR or BHll primary antibody as in- 
dicated beneath the corresponding panel. 
Such cells showed AChR staining of patches 
or diffuse utrophinldystrophin staining similar 
to that shown in the top two panels, but no 
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Figure 6. Schematic Model of the Hypothetical Molecular Organization of the Postsynaptic Apparatus at the Neuromuscular Junction 
Shown are the molecules proposed to play a role in AChR clustering at the neuromuscular junction, arranged with predicted interactions depicted. 
Apparent molecular weights that originally defined each depicted protein are indicated at the right; on the left, alternative names are shown. We 
encourage the use of the names rapsyn and 6-dystroglycan to differentiate these 43 kDa proteins. This is especially important in light of the recent 
distinction of yet another 43 kDa DGC component as a unique species. We propose that rapsyn links the AChR to the DGC, thereby facilitating 
the association of AChR clusters with the cytoskeleton. Biochemical analysis of Torpedo electric organ postsynaptic membranes suggests a 1:l 
stoichiometry of AChR and rapsyn (LaRochelle and Froehner, 1966) but other components appear to be less abundant, consistent with our 
proposal that the formation of mature clusters involves the linkaqe of many AChR-rapsyn small clusters to each dystroglycan molecule (see text 
for further explanation). 
tween the AChR and the DGC (Figure 6). Furthermore, 
utrophinldystrophin does not appear to play a necessary 
role in this linkage. 
Discussion 
We have investigated the interaction between the AChR 
and the DGC using the QT-6 heterologous cell system. 
QT-6 cells lack rapsyn and AChR, as well as any detect- 
able dystroglycan; yet recombinant rapsyn and AChR 
readily form clusters when coexpressed by transfection 
in these fibroblasts, thereby making this an ideal system 
for reconstitution experiments. The introduction of one 
component of the DGC, dystroglycan, into QT-6 cells coex- 
pressing AChR and rapsyn resulted in the codistribution 
of dystroglycan to AChR-rapsyn clusters. Dystroglycan 
expressed by itself, however, was found evenly distributed 
across the ceil. This is in contrast to rapsyn, which forms 
clusters when expressed alone in QT-6 cells. Dystroglycan 
association with clusters, therefore, is likely to occur as 
a secondary event and is not needed to initiate cluster 
formation; rather, the role of dystroglycan in cluster forma- 
tion in native muscle may be to provide an anchor point 
within the cytoskeleton-associated DGC complex to which 
clusters bind and are thereby stably linked to the cyto- 
skeleton. 
When dystroglycan and rapsyn were coexpressed in the 
absence of AChR, dystroglycan was found colocalized 
with rapsyn clusters. AChR is therefore not necessary for 
the observed interaction between dystroglycan and clus- 
ters. Since adhalin was undetectable in QT-6 cells, this 
t ransmembrane DGC component does not mediate the 
rapsyn-dystroglycan interaction. Utrophinldystrophin also 
does not appear to mediate this interaction, since immuno- 
f luorescence staining of an endogenous species recog- 
nized by an anti-utrophin antibody demonstrated no colo- 
calization with dystroglycan-containing clusters. The lack 
of species cross-reactive antibodies made it impossible 
for us to determine whether other AChR-associated and 
DGC proteins are present in rapsyn-dystroglycan clus- 
ters. However,  it is improbable that dystrophin, the DGC 
transmembrane 35 kDa protein, or the 87 kDa protein me- 
diate the rapsyn-dystroglycan interaction: these proteins 
are not likely to be present in QT-6 fibroblasts, as their 
expression appears to be restricted to muscle and the 
nervous system (Hoffman et al., 1987; Lev et al., 1987; 
Chamberlain et al., 1988; Nude1 et al., 1988; Matsumura 
et al., 1993; Wagner et al., 1993; Yamamoto et al., 1994). 
Isolation of cDNAsfor syntrophin has revealed a multigene 
family of syntrophin proteins (Adams et al., 1993; Ahn et 
al., 1994; Yang et al., 1994), and although one or more 
of these isoforms may be present in QT-6 cells, in vitro 
binding assays indicate that syntrophin does not interact 
directly with dystroglycan (Yang et al., 1995). Furthermore, 
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coimmunoprecipitation and coimmunoaffinity purification 
experiments demonstrated that rapsyn was not present 
in isolated complexes containing syntrophin or the 87 kDa 
protein, again arguing against the possibility that syn- 
trophin or the 87 kDa protein mediate the rapsyn-dystro- 
glycan interaction (Butler et al., 1992; Wagner et al., 1993). 
Future biochemical approaches will clearly be necessary 
to determine whether one or more additional proteins me- 
diate the observed association of rapsyn with dystrogly- 
can, or whether the interaction may be direct. 
Multiple lines of evidence implicate the DGC in AChR 
clustering. The DGC is an oligomeric t ransmembrane 
complex that binds to utrophin at the synapse, and 
utrophin in turn associates with actin to anchor the DGC to 
the submembrane cytoskeleton (see Figure 6). The recent 
discovery that agrin binds to a-dystroglycan suggests that 
the DGC may serve as a link between the extracellular 
binding of agrin and the intracellular events that mediate 
formation of AChR clusters (Bowe et al., 1994; Campanelli 
et al., 1994; Geeetal., 1994; Sugiyamaet al., 1994). Previ- 
ous indications of the importance of the DGC in AChR 
clustering came from the increasing emphasis on the colo- 
calization of utrophin at AChR clusters (Khurana et al., 
1991; Ohlendieck et al., 1991a; Bewick et al., 1992; Phil- 
lips et al., 1993; Campanelli et al., 1994; Gee et al., 1994), 
as well as the realization that a 59 kDa DGC-associated 
protein is identical to the AChR-associated protein syn- 
trophin (Adams et al., 1993; Yang et al., 1994). Further- 
more, DGC components are enriched at the synapse, in 
addition to being found in extrasynaptic sarcolemmal 
membranes (Matsumuraet al., 1992). Although it remains 
to be determined whether agrin binding to a-dystroglycan 
plays a part in AChR clustering, a structural role for the 
DGC in AChR clustering is strongly implied. One function 
of the DGC may therefore be to provide a scaffolding 
through which AChRs may stably associate with the cy- 
toskeleton, thereby promoting the formation or mainte- 
nance of high density clusters. Our  finding that rapsyn 
mediates the interaction between the AChR and the DGC 
provides molecular evidence to connect these two halves 
of the postsynaptic apparatus (see Figure 6). Rapsyn may 
therefore be a necessary link in the chain of proteins con- 
necting the AChR to the cytoskeleton. 
Our  observation that endogenous utrophinldystrophin 
does not colocalize with clusters formed in QT-6 fibro- 
blasts is surprising in light of the well-established interac- 
tions between dystrophin and utrophin and the DGC, and 
of the proposed role of utrophin in cluster formation (Er- 
vasti et al., 1990; Yoshida and Ozawa, 1990; Ervasti and 
Campbell, 1991; Khurana et al., 1991; Ohlendieck et al., 
1991a; Bewick et al., 1992; Matsumura et al., 1992; Phil- 
lips et al., 1993; Campanelli et al., 1994; Gee et al., 1994; 
Suzuki et al., 1994). Experiments with C2 muscle cells 
demonstrated that, while dystrophin was undetected in 
these cells, utrophin was found at large clusters but not 
small clusters, implying a role for utrophin in the matura- 
tion of clusters rather than in their initial formation (Phillips 
et al., 1993). Similarly, it is possible that clusters found in 
QT-6 cells represent an immature form of clusters that 
have not stably associated with the cytoskeleton. The reg- 
ulatory factors that allow maturing clusters to connect to 
the cytoskeleton may be missing or inactive in QT-6 cells. 
Alternatively, perhaps the rabbit dystroglycan expressed 
in QT-6 cells does not bind to the endogenous quail 
utrophin or dystrophin because of species differences. 
Binding of utrophin to 6-dystroglycan has yet to be demon- 
strated, but the homology between utrophin and dys- 
trophin, which does bind directly to f3-dystroglycan (Suzuki 
et al., 1994) suggests that such interactions are likely. 
Finally, it is possible that clusters may interact with other 
cytoskeletal proteins besides utrophin or dystrophin, as 
suggested by the observation that AChR-rapsyn clusters 
in QT-6 cells are partially resistant to extraction with Triton 
X-100 (Phillips et al., 1993). Regardless of why clusters 
in QT-6 cells have no associated endogenous utrophin/ 
dystrophin, our results demonstrate that at the molecular 
level utrophinldystrophin is not required for rapsyn to inter- 
act with 6-dystroglycan; instead, rapsyn can directly link 
the AChR with the transmembrane DGC components, in- 
dependently of the involvement of this cy-toskeletal protein. 
Our  results indicating that rapsyn links the AChR to the 
DGC provide a critical advance in our understanding of 
the molecular architecture of the postsynaptic apparatus 
(see Figure 6). However,  a number of uncertainties con- 
cerning the organization and function of other relevant 
AChR-associated and DGC proteins still remain. For ex- 
ample, if rapsyn is the molecular link between the AChR 
and the cytoskeleton-associated DGC, what are the func- 
tions of syntrophin and the 87 kDa protein, which were 
previously proposed to anchor the AChR to the cytoskele- 
ton (Cartaud et al., 1981; Bloch et al., 1991; Froehner, 
1991; Adams et al., 1993; Wagner et al., 1993)? We hy- 
pothesize that syntrophin and the 87 kDa protein are not 
necessary for linking the AChR to the DGC, but rather 
may play a structural or regulatory role in linking the DGC 
to the cytoskeleton. In addition, many of the molecules 
thought to play a role in agrininduced AChR clustering 
are found throughout the sarcolemmal membrane and are 
not restricted to the synaptic membrane as one might have 
expected. How then is the participation of these proteins 
in events underlying AChR clustering restricted to the syn- 
apse where AChRs are clustered? The specificity must 
derive from associations between these proteins and mol- 
ecules unique to the synapse; extrajunctionally, they may 
interact with different molecules to carry out functions un- 
related to AChR clustering. For example, evidence from 
both normal and dystrophic muscle indicates that the DGC 
plays a critical role in muscle membrane structure and 
function throughout the fiber, and stabilizing interactions 
between the DGC and dystrophin appear to be necessary 
for this function (reviewed in Matsumura and Campbell, 
1994). At the synapse, however, the DGC interacts with 
synaptically localized utrophin and through this spatially 
restricted interaction may play a specialized role in AChR 
clustering (Khurana et al., 1991; Ohlendieck et al., 1991 a; 
Bewick et al., 1992; Matsumura et al., 1992; Phillips et 
al., 1993). Rapsyn and one of the syntrophin isoforms are 
also unique to the synapse (Froehner et al., 1981; Sealock 
et al., 1984; Peters et al., 1994) and the participation of 
the DGC in the events that underlie AChR clustering may 
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be restricted to the neuromuscular junction through an 
interaction with these synaptically localized proteins. 
To understand the function of the DGC and associated 
proteins in AChR clustering, it is essential to identify all 
the proteins with which the DGC and AChR complex com- 
ponents associate. Our  results demonstrate that rapsyn 
can interact independently with dystroglycan and AChR, 
and thereby may be a molecular link connecting the AChR 
to the DGC. Our  results further suggest that rapsyn can 
link the AChR directly to the DGC through interactions 
with dystroglycan, and not through association with the 
DGC-associated cytoskeletal anchor utrophinldystrophin. 
By linking the AChR to one member of the cytoskeleton- 
anchored DGC, dystroglycan, rapsyn may mediate the as- 
sociation of the AChR with the cytoskeleton. 
Experimental Procedures 
Antibodies 
The following primary antibodies were used: anti-rapsyn rabbit poly- 
clonal antibody 5943 (Phillips et al., 1991 b), anti-AChR rat monoclonal 
antibody mAb61 (Tzarlos et al., 1981) anti-dystroglycan sheep poly- 
clonal antibody FP-B (Ibraghimov et al. I 1992) anti-b-dystroglycan rab- 
bit polyclonal antibody previously designated “43 C-terminal” (Ibrag- 
himov et al., 1992) anti-a-dystroglycan mouse monoclonal llH6 
(Ibraghimov et al., 1992) and anti-utrophin rabbit polyclonal antibody 
BHll (Khuranaet al., 1991). Secondary antibodies used in immunoflu- 
orescence staining included TRITC-goat anti-rabbit IgG (Boehringer 
Mannheim, Indianapolis, IN), TRITC-rabbit anti-rat IgG (SigmaChem- 
ical, St. Louis, MO), Cy3-donkey anti-rabbit lgG (Jackson ImmunoRe- 
search Laboratories, Inc., West Grove, PA), FITC-donkey anti-sheep 
IgG (Sigma), and FITC-goat anti-rat IgG (Boehringer Mannheim). Sec- 
ondary antibodies used in Western blotting included peroxidase- 
conjugated goat anti-rabbit IgG (Boehringer Mannheim), goat antr- 
mouse IgM (Boehringer Mannheim), and donkey anti-sheep IgG 
(Sigma). 
Western Blot Analysis 
Rabbit and quail muscle crude surface membranes were prepared as 
described previously (Ohlendieck et al., 1991 b). Whole-cell pellets of 
QT-6 cell cultures were solubilized in modified Laemmli buffer (Laem- 
mli, 1970). For blots probed with antibodies llH6 and BHll, samples 
were separated on 3%-120/o gradient SDS-polyacrylamide gels, 
transferred to nitrocellulose, and stained as previously described (Oh- 
lendieck et al., 1991 b). llH6 was used at a concentration of 3 nglml, 
and BHll was diluted 1:2000 before use. For all other blots, QT-6 
samples from nontransfected and transfected cells were separated 
on 7.5% or 10% polyacrylamide gels and transferred to nitrocellulose 
(0.45 nm; Schleicher & Schuell, Inc., Keene, NH). Transfer was carried 
out in 96 mM glycine, 12.5 mM Tris, 20% (v/v) methanol for 75 min 
at 400 mA. Nitrocellulose transfers were blocked overnight at 4°C 
in PBS/Tween-20 (phosphate-buffered saline with 0.5% Tween-20) 
containing 5% nonfat dry milk, followed by incubation with primary 
antibody for 2 hr at room temperature. Primary antibodies were diluted 
into PBSfTween-20 containing 2.5% nonfat dry milk and used at dilu- 
tions of 1:500 (antibody 5943) I:25 (FP-B), and 1:2000 @-dystroglycan- 
specific antibody). After washing once for 15 min, then four times 
for 5 min each in PBS/Tween-20, filters were incubated for 1 hr with 
secondary antibodies diluted 1:2000 in PBSITween-20 containing 
2.5% nonfat dry milk. Filters were washed again once for 15 min and 
four times for 5 min, incubated for 1 min in chemiluminescence re- 
agents according to the manufacturer’s instructions (DuPont NEN, 
Boston, MA), and exposed to film (X-Omat, Kodak) for varying amounts 
of time. 
Expression Constructs 
The cDNAs for mouse rapsyn, mouse AChR subunits (a, 6. y, and 6), 
and rabbit dystroglycan were each expressed from similar constructs 
consisting of a pSKII(+) plasmid backbone (Stratagene, San Diego, 
CA) and the specified cDNA under the control of the Rous sarcoma 
virus long terminal repeat. The rapsyn and AChR expression con- 
structs have been described previously (Phillips et al., 1991a; Mai- 
mone and Merlie, 1993). To construct the dystroglycan expression 
plasmid, the rapsyn coding region was removed from the rapsyn ex- 
pression vector and replaced by a portion of the rabbit dystroglycan 
cDNA (Ibraghimov et al., 1992). Specifically, a 3.4 kb Bglll-EcoRV 
fragment containing the entire coding region of the rabbit dystroglycan 
cDNA was ligated with a 3.7 kb Xmal-Ncol fragment from the rapsyn 
expression construct after both fragments were made blunt with 
Klenow. The latter contained the intact Rous sarcoma virus long termi- 
nal repeat directly 5’ of the insertion site and the AChR a subunit 
polyadenylation signal 3’of the Ncol site. The ligation junctions were 
sequenced to confirm correct insertion and maintenance of the correct 
reading frame. 
Cell Culture and Transfection 
The quail fibroblast cell line, QT-6 (Moscovici et al., 1977) was main- 
tained as previously described (Blount and Merlie, 1988). For immuno- 
fluorescence staining studies, QT-6 cells were plated onto glass cov- 
erslips (13 mm diameter) in 6 cm tissue culture dishes and transfected 
I day later when cells were 25%-50% confluent. For Western blot 
analysis, QT-6cellswereplateddirectlyonto6cm tissueculturedishes 
and transfected 1-2 days later when cells reached 60%-90% conflu- 
ency. Cells were transfected using the calcium phosphate precipitation 
method of Chen and Okayama (1987) modified as previously described 
(Phillips et al., 1991 b). A total of 4 ug of each plasmid was used, and 
pSKII(+) was added as necessary to bring the total amount of plasmid 
transfected per 6 cm dish to 24 pg. Transfection efficiencies typically 
ranged from 40% to 60%. 
lmmunofluorescence Staining 
QT-6 cells on glass coverslips were washed with PBS and then fixed 
for 20 min in PBS containing 1% paraformaldehyde, 100 mM L-lysine, 
10 mM sodium meta-periodate. and 1% saponin. After rinsing with 
PBS, cell were permeabilized for 10 min in 1% Triton X-100 in PBS, 
washed three times in PBS, and stored overnight in 1% fetal calf serum 
in PBS. Coverslips were inverted (cell side down) onto 50 aI drops of 
primary antibody and incubated for 2 hr at room temperature. Cells 
were frequently incubated with two antibodies simultaneously to facili- 
tate visualization of potential colocalization. Primary antibodies were 
diluted I:50 (antibody 5943) I:250 (FP-B), 1: lOOO (BHll), and 1:200 
(mAb61) in PBS containing 1% fetal calf serum. Coverslips were 
washed three times with PBS, inverted onto 50 pl drops of secondary 
antibody diluted in PBS with 1% fetal calf serum, and incubated for 
1 hr at room temperature. Secondary antibodies were used at dilutions 
of 1:500 (TRITC-rabbit anti-rat), 1:25 (FITC-donkey anti-sheep), 
1:5000 (Cy3-donkey anti-rabbit), and 1:200 (TRITC-goat anti-rabbit 
and FITC-goat anti-rat). After washing three times in PBS, coverslips 
were finally rinsed briefly in distilled water and mounted for fluores- 
cence microscopy onto an antifading mountant (Johnson and No- 
gueira Araujo, 1981). To visualize staining of extracellular epitopes, 
cells were fixed with 1% paraformaldehyde and were not permeabil- 
ized, but were otherwise processed as described above. To control 
for fluorescent cross-bleed and antibody specificity in double-labeling 
experiments, parallel coverslips were stained in the absence of either 
of the two primary antibodies. The specificity of each primary antibody 
was confirmed using nontransfected cells. 
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